This is the first year MCC is conducting a mass casualty simulation. It gives future nursing and paramedicine students the ...
A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General ...
The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...